KJ
Kanishk Jain
About Kanishk Jain
Data last updated:
Kanishk Jain is a Director at Akumentis Healthcare Limited (since 2020) and Director at American Remedies Lifesciences Limited (since 2020). The companies operate in Pharma and Business Services. The largest current company by reported revenue is Akumentis Healthcare Limited at ₹464 Cr (FY 2026). Earlier, Kanishk Jain was a Partner at Dhanwantri Vedaresearch Llp (2023–2024) and Additional Director at Delcure Lifesciences Limited (2018–2019) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Akumentis Healthcare Limited U72900DL2010PLC206414 | Director | 29 Jun 2020 | 2010 | ₹464 Cr (FY 2026) | Active |
 American Remedies Lifesciences Limited U24299DL2020PLC371493 | Director | 13 Oct 2020 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Dhanwantri Vedaresearch Llp AAU-0167 | Partner | 15 Mar 2023 | 2020 | ₹3,085 (FY 2026) | Active |
 Delcure Lifesciences Limited U24100DL2013PLC286876 | Additional Director | 30 Sep 2018 | 2013 | ₹30,000 (FY 2026) | Active |
 Aleafiaa Pharmaceuticals Private Limited U74999MH2017PTC301818 | Director | 26 Dec 2018 | 2017 | ₹17 Lakh (FY 2024) | Active |
| German Remedies Lifesciences Limited U24304DL2020PLC371884 | Director | 20 Oct 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kanishk Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Kumar Dhiman | Akumentis Healthcare Limited | Ceo | |
| Mohammad Shahbaz Alam | 06824697 | Akumentis Healthcare Limited | Director |
| Neena Vivek | 07118115 | Akumentis Healthcare Limited | Director |
| Rajneesh Mehta | 11516932 | Akumentis Healthcare Limited | Director |
| Sanjay Chandrakant Chalke | 07679410 | Akumentis Healthcare Limited | Whole-Time Director |
| Arushi Jain | 08012943 | American Remedies Lifesciences Limited | Director |
| Rashmi Gupta | 02583595 | American Remedies Lifesciences Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kanishk Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kanishk Jain
Kanishk Jain currently holds 2 directorships: Akumentis Healthcare Limited (Director, since 29 Jun 2020, revenue ₹464 Cr (FY 2026)); American Remedies Lifesciences Limited (Director, since 13 Oct 2020).
Kanishk Jain was first appointed on 30 Sep 2018 as Additional Director at Delcure Lifesciences Limited. The most recent appointment on record is 15 Mar 2023 at Dhanwantri Vedaresearch Llp.
Kanishk Jain held 4 earlier board appointments: Dhanwantri Vedaresearch Llp (Partner, 15 Mar 2023 to 29 Mar 2024); Delcure Lifesciences Limited (Additional Director, 30 Sep 2018 to 30 Jun 2019); Aleafiaa Pharmaceuticals Private Limited (Director, 26 Dec 2018 to 30 Mar 2021); German Remedies Lifesciences Limited (Director, from 20 Oct 2020).
The current boards of Kanishk Jain's companies include Ajay Kumar Dhiman (Akumentis Healthcare Limited), Mohammad Shahbaz Alam (Akumentis Healthcare Limited), Neena Vivek (Akumentis Healthcare Limited), Rajneesh Mehta (Akumentis Healthcare Limited), Sanjay Chandrakant Chalke (Akumentis Healthcare Limited), Arushi Jain (American Remedies Lifesciences Limited), among others.